Plus therapeutics to participate in upcoming january conferences

Austin, texas, jan. 07, 2022 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced that marc h. hedrick m.d., president and chief executive officer of plus therapeutics, will participate at two virtual conferences in january.
PSTV Ratings Summary
PSTV Quant Ranking